Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient monitoring, proactive adverse effect management, and adapting protocols ...

A new study from Karolinska Institutet shows how a small antibody fragment can block fertilisation by targeting a key protein on the surface of the ...

Top-down proteomics: Intact proteins are ionized and analyzed directly, allowing for the study of proteoforms and ...

The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields. Both formulations ...

Detailed price information for Briacell Therapeutics Corp (BCTX-Q) from The Globe and Mail including charting and trades.

Immunizing mice with an edited Lyme disease-causing bacterial protein effectively protected them against the disease.

“By combining patient samples and functional insights from Yale with the molecular resolution of cryo-EM and biophysics from ...

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in the disease.

parsing unique molecular identifiers (UMIs), and building/using custom germline databases. These are described in the abstar documentation.